Stay updated on Cabozantinib & 13-cisRA in Children Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib & 13-cisRA in Children Clinical Trial page.

Latest updates to the Cabozantinib & 13-cisRA in Children Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedThe page update is limited to a revision label change from v3.4.1 to v3.4.2 and does not modify study content, eligibility criteria, contacts, or trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page shows a minor system revision from v3.4.0 to v3.4.1; no user-facing study details or eligibility information were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page now displays a 'Last Update Posted' label, replacing the previous 'Last Update Posted (Estimated)' label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3. These changes reflect the page's version history rather than any modification to study details or eligibility.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded a Locations section with California and Georgia, reorganizing location information. Removed the HHS Vulnerability Disclosure link and updated the revision to v3.3.3.SummaryDifference0.3%

Stay in the know with updates to Cabozantinib & 13-cisRA in Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib & 13-cisRA in Children Clinical Trial page.